LOW CYP1A2 ACTIVITY IN RURAL SHONA CHILDREN OF ZIMBABWE

被引:16
作者
MASIMIREMBWA, CM
BEKE, M
HASLER, JA
TANG, BK
KALOW, W
机构
[1] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON M5S 1A8,CANADA
[2] UNIV ZIMBABWE,DEPT BIOCHEM,HARARE,ZIMBABWE
关键词
D O I
10.1016/0009-9236(95)90262-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Caffeine is increasingly used as a biochemical probe for liver function, in cancer epidemiology, and in pharmacogenetics, with its recognized ability to assess the activities of CYP1A2, xanthine oxidase, and N-acetyltransferase-2. The activity of these hepatic enzymes was tested in 45 Shona children from a rural area of Zimbabwe with use of caffeine as a probe. Many of these rural black children had lower indexes of CYP1A2 activity than otherwise on our extensive records; the average value (3.78 +/- 2.9) was significantly (p < 0.001) lower than that of healthy white urban children from Zimbabwe (8.86 +/- 3.36) or from Canada (7.92 +/- 1.88), or that of healthy Canadian adults (5.96 +/- 2.4). A higher CYP1A2 activity in children than in adults is usual. The low CYP1A2 activity of the children from rural Zimbabwe calls for medical studies and suggests a widespread and perhaps serious impairment of certain liver functions. Causes could be parasitic infections with Schistosoma mansoni, causing schistosomiasis, which are endemic, in addition to generally poor nutrition and frequent iodine deficiency. By contrast, the xanthine oxidase activity in rural Shona children was slightly higher than that reported for a healthy Canadian adult population. The N-acetyltransferase activities were comparable in both the rural and urban children and were also similar to those reported in a population study of healthy adult Canadians.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 41 条
[1]   DETERMINATION OF THEOPHYLLINE CLEARANCE IN SOUTH-AFRICAN CHILDREN [J].
BOTHA, JH ;
TYRANNES, I ;
MILLER, R ;
WESLEY, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (04) :369-375
[2]  
CAMPBELL ME, 1987, THESIS U TORONTO TOR
[3]  
CAMPBELL TC, 1974, PHARMACOL REV, V26, P171
[4]  
CHA YN, 1976, J PHARMACOL EXP THER, V199, P432
[5]  
DARCY PF, 1986, PHARM INT, V7, P75
[6]   THE PHARMACOKINETICS OF ANTIPYRINE IN PATIENTS WITH GRADED SEVERITY OF SCHISTOSOMIASIS [J].
ELRAGHY, I ;
BACK, DJ ;
OSMAN, F ;
NAFEH, MA ;
ORME, ML .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (04) :313-316
[7]  
GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243
[8]  
GRAM LF, 1993, 5TH P EUR ISSX M TOU, V3, P74
[9]   VARIABILITY IN CAFFEINE METABOLISM [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) :591-602
[10]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407